Human neuroblastoma cell lines regain catecholamine fluorescence when xenografted into athymic (nude) mice

International Journal of Developmental Neuroscience

Volumn 14, Issue 6, 1996, Pages 771-777

  Tomayko, Mary M ^a,b   Triche, Timothy J ^a,b   Reynolds, C Patrick ^a,b  

^a CHILDREN S HOSPITAL LOS ANGELES   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Athymic (nude) mice; Catecholamine fluorescence; Catecholamines; Digital image microscopy; Electron microscopy; Neuroblastoma

Indexed keywords

CATECHOLAMINE;

ANIMAL EXPERIMENT; ARTICLE; CANCER CELL CULTURE; CATECHOLAMINE SYNTHESIS; CELL GRANULE; CELL ULTRASTRUCTURE; CONTROLLED STUDY; FLUORESCENCE; HISTOCHEMISTRY; HUMAN; HUMAN CELL; MOUSE; NERVE GRAFT; NEUROBLASTOMA CELL; NEUROECTODERM TUMOR; NEUROSECRETORY CELL; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; XENOGRAFT;

ANIMALS; CATECHOLAMINES; CELL DIVISION; FLUORESCENT DYES; HUMANS; MICE; MICE, NUDE; MICROSCOPY, ELECTRON; NEUROBLASTOMA; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

ANIMALIA; MUS MUSCULUS;

EID: 0030569595     PISSN: 07365748     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0736-5748(96)00050-0     Document Type: Article

References (29)

1. 1. Biedler J. L., Helson L. and Spengler B. A. (1973) Morphology and growth, tumorigenicity, and cytogenetics of human neuroblastoma cells in continuous culture. Cancer Res. 33, 2643-2652.
2. 2. Biedler J. L., Roffler-Tarlov S., Schachner M. and Freedman L. S. (1978) Multiple neurotransmitter synthesis by human neuroblastoma cell lines and clones. Cancer Res. 38, 3751-3758.
3. 3. De la Torre J. C. and Surgeon J. W. (1976) A methodological approach to rapid and sensitive monoamine histofluorescence using a modified glyoxylic acid technique: the SPG method. Histochemistry 49, 81-93.
4. 4. De la Torre J. C. (1980) An improved approach to histofluorescence using the SPG method for tissue monoamines. J. Neurosci. Meth. 3, 1-5.
5. 5. Gash D. M., Notter M. F., Okawara S. H., Kraus A. L. and Joynt R. J. (1986) Amitotic neuroblastoma cells used for neural implants in monkeys. Science 233, 1420-1422.
6. 6. Gelfand M. J. (1993) Meta-iodobenzylguanidine in children. Semin. Nucl. Med. 23, 231-242.
7. 7. Helson L., Nisselbaum J., Helson C., Majeranowski A. and Johnson G. A. (1980) Biological markers in neuroblastoma and other pediatric neoplasias. In Human Cancer: Its Characterization and Treatment (ed. Davis W., Harrap K. R. and Stathopoulous G.), pp. 86-94. Excerpta Medica, Princeton, New Jersey.
8. 8. LaBrosse E. H., Com-Nougue C., Zucker J. M., Comoy E., Bohuon C., Lemerle J. and Schweisguth O. (1980) Urinary excretion of 3-methyl-4-hydroxymandelic acid and 3-methoxy-r-hydroxyphenylacetic acid by 288 patients with neuroblastoma and related neural crest tumors. Cancer Res. 40, 1995-2001.
9. 9. Lee B. R., Haseman D. B. and Reynolds C. P. (1989) A digital image microscopy system for rare event detection using fluorescent probes. Cytometry 10, 256-262.
10. 10. Mains R. E. and Patterson P. H. (1973) Primary cultures of dissociated sympathetic neurons. II. Initial studies on catecholamine metabolism. J. Cell Biol. 59, 346-360.
11. 11. Manaster J. S., Feuerman T., Reynolds C. P. and Markham C. H. (1992) Transplantation of human neuroblastoma cells, catecholaminergic and non-catecholaminergic: effects on rotational behavior in Parkinson's rat model. J. Neur. Transpl. Plast. 3, 139-150.
12. 12. McGarrity G. J., Sarama J. and Vanaman V. (1979) Factors influencing microbiological assay of cell-culture mycoplasmas. In Vitro 15, 73-81.
13. 13. Perez-Polo J. R., Reynolds C. P., Tiffany-Castiglioni E., Ziegler M., Schulze I. and Werrback-Perez K. (1982) NGF effects on human neuroblastoma lines: a model system. Progr. Clin. Biol. Res. 79, 285-299.
14. 14. Potluri V. R., Gilbert F., Helson C. and Helson L. (1987) Primitive neuroectodermal tumor cell lines: chromosomal analysis of five cases. Cancer Genet. Cytogenet. 24, 75-86.
15. 15. Puls J. H., Bibbo M., Dytch H. E., Bartels P. H. and Wied G. L. (1986) The design of an inexpensive video-based microphotometer/computer system for DNA ploidy studies. Anal. Quan. Cytol. Hist. 8, 1-7.
16. 16. Reynolds C. P., German D. C., Weinberg A. G. and Smith R. G. (1981) Catecholamine fluorescence and tissue culture morphology. Techniques in the diagnosis of neuroblastoma. Am. J. Clin. Pathol. 75, 275-282.
17. 17. Reynolds C. P., Smith R. G. and Frenkel E. P. (1981) The diagnostic dilemma of the small round cell neoplasm: catecholamine fluorescence and tissue culture morphology as markers for neuroblastoma. Cancer 48, 2088-2094.
18. 18. Reynolds C. P. and Smith R. G. (1982) Diagnostic and biological markers for neuroblastoma. In: Neuroblastoma Clinical and Biological Manifestations (ed. Pochedly C.), pp. 131-168. Elsevier Biomedical, New York.
19. 19. Reynolds C. P., Reynolds D. A., Frenkel E. P. and Smith R. G. (1982) Selective toxicity of 6-hydroxydopamine and ascorbate for human neuroblastoma in vitro: a model for cleaning marrow prior to autologous transplant. Cancer Res. 42, 1331-1336.
20. 20. Reynolds C. P., Biedler J. L., Spengler B. A., Reynolds D. A., Ross R. A., Frenkel E. P. and Smith R. G. (1986) Characterization of human neuroblastoma cell lines established before and after therapy. J. Natl Cancer. Inst. 76, 375-387.
21. 21. Reynolds C. P., Tomayko M. M., Donner L., Helson L., Seeger R. C., Triche T. J. and Brodeur G. M. (1988) Biological classification of cell lines derived from human extra-cranial neural tumors. Progr. Clin. Biol. Res. 271, 291-306.
22. 22. Ross R., Biedler J., Spengler B. and Reis D. (1981) Neurotransmitter-synthesizing enzymes in 14 human neuroblastoma cell lines. Cell Mol. Neurobiol. 1, 301-312.
23. 23. Schlesinger H. R., Rorke L., Jamieson R. and Hummeler K. (1981) Neuronal properties of neuroectodermal tumors in vitro. Cancer Res. 41, 2573-2575.
24. 24. Schlesinger H. R., Gerson J. M., Moorhead P. S., Maguire H. and Hummeler K. (1976) Establishment and characterization of human neuroblastoma cell lines. Cancer Res. 36, 3094-3100.
25. 25. Seeger R. C., Danon Y. L., Rayner S. A. and Hoover F. (1982) Definition of a Thy-1 determinant on human neuroblastoma, glioma, sarcoma, and teratoma cells with a monoclonal antibody. J. Immunol. 128, 983-989.
26. 26. Thiele C. J., McKeon C., Triche T. J., Ross R. A., Reynolds C. P. and Israel M. A. (1987) Differential proto-oncogene expression characterizes histopathologically indistinguishable tumors of the peripheral nervous system. J. Clin. Invest. 80, 804-811.
27. 27. Tomayko M. M. and Reynolds C. P. (1989) Determination of subcutaneous tumor size in athymic (nude) mice. Cancer Chemother. Pharmacol. 24, 148-154.
28. 28. Wada R. K., Seeger R. C., Brodeur G. M., Rayner S. A., Tomayko M. M. and Reynolds C. P. (1993) N-myc expression in human neuroblastoma cell lines without N-myc gene amplification. Cancer 72, 3346-3354.
29. 29. Whang-Peng J., Triche T. J., Knutsen T., Miser J., Kao-Shan S., Tsai S. and Israel M. A. (1986) Cytogenetic characterization of selected small round cell tumors of childhood. Cancer Genet. Cytogenet. 21, 185-208.